Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib in imatinib- and sunitinib-resistant gastrointestinal stromal tumors
2008-000357-35Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nilotinib in gastrointestinal stromal tumor (GIST), sponsored by Novartis. Started Aug 2008; status: completed.
02
Drugs
nilotinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on 2008-000357-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000357-35.